149 related articles for article (PubMed ID: 35237662)
21. A Novel Therapeutic Peptide Blocks SARS-CoV-2 Spike Protein Binding with Host Cell ACE2 Receptor.
Rajpoot S; Ohishi T; Kumar A; Pan Q; Banerjee S; Zhang KYJ; Baig MS
Drugs R D; 2021 Sep; 21(3):273-283. PubMed ID: 34324175
[TBL] [Abstract][Full Text] [Related]
22. Potential chimeric peptides to block the SARS-CoV-2 spike receptor-binding domain.
Barh D; Tiwari S; Silva Andrade B; Giovanetti M; Almeida Costa E; Kumavath R; Ghosh P; Góes-Neto A; Carlos Junior Alcantara L; Azevedo V
F1000Res; 2020; 9():576. PubMed ID: 32802318
[No Abstract] [Full Text] [Related]
23. 1,2,3,4,6-Pentagalloyl Glucose, a RBD-ACE2 Binding Inhibitor to Prevent SARS-CoV-2 Infection.
Chen RH; Yang LJ; Hamdoun S; Chung SK; Lam CW; Zhang KX; Guo X; Xia C; Law BYK; Wong VKW
Front Pharmacol; 2021; 12():634176. PubMed ID: 33897423
[TBL] [Abstract][Full Text] [Related]
24. Structural analysis of integrin recognition and the inhibition of integrin-mediated cell functions by novel nonpeptidic surrogates of the Arg-Gly-Asp sequence.
Greenspoon N; Hershkoviz R; Alon R; Varon D; Shenkman B; Marx G; Federman S; Kapustina G; Lider O
Biochemistry; 1993 Feb; 32(4):1001-8. PubMed ID: 8093840
[TBL] [Abstract][Full Text] [Related]
25. Control of Integrin Affinity by Confining RGD Peptides on Fluorescent Carbon Nanotubes.
Polo E; Nitka TT; Neubert E; Erpenbeck L; Vuković L; Kruss S
ACS Appl Mater Interfaces; 2018 May; 10(21):17693-17703. PubMed ID: 29708725
[TBL] [Abstract][Full Text] [Related]
26. Crystal structure of trimestatin, a disintegrin containing a cell adhesion recognition motif RGD.
Fujii Y; Okuda D; Fujimoto Z; Horii K; Morita T; Mizuno H
J Mol Biol; 2003 Oct; 332(5):1115-22. PubMed ID: 14499613
[TBL] [Abstract][Full Text] [Related]
27. Corilagin and 1,3,6-Tri-
Binette V; Côté S; Haddad M; Nguyen PT; Bélanger S; Bourgault S; Ramassamy C; Gaudreault R; Mousseau N
Phys Chem Chem Phys; 2021 Jul; 23(27):14873-14888. PubMed ID: 34223589
[TBL] [Abstract][Full Text] [Related]
28. Integrin activation is an essential component of SARS-CoV-2 infection.
Simons P; Rinaldi DA; Bondu V; Kell AM; Bradfute S; Lidke D; Buranda T
bioRxiv; 2021 Jul; ():. PubMed ID: 34312625
[TBL] [Abstract][Full Text] [Related]
29. Biomechanical characterization of SARS-CoV-2 spike RBD and human ACE2 protein-protein interaction.
Cao W; Dong C; Kim S; Hou D; Tai W; Du L; Im W; Zhang XF
Biophys J; 2021 Mar; 120(6):1011-1019. PubMed ID: 33607086
[TBL] [Abstract][Full Text] [Related]
30. Potential for developing a SARS-CoV receptor-binding domain (RBD) recombinant protein as a heterologous human vaccine against coronavirus infectious disease (COVID)-19.
Chen WH; Hotez PJ; Bottazzi ME
Hum Vaccin Immunother; 2020 Jun; 16(6):1239-1242. PubMed ID: 32298218
[TBL] [Abstract][Full Text] [Related]
31. Molecular insights into the binding variance of the SARS-CoV-2 spike with human, cat and dog ACE2 proteins.
Zang Y; Li X; Zhao Y; Wang H; Hao D; Zhang L; Yang Z; Yuan X; Zhang S
Phys Chem Chem Phys; 2021 Jun; 23(24):13752-13759. PubMed ID: 34132301
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of molecular interaction, physicochemical parameters and conserved pattern of SARS-CoV-2 Spike RBD and hACE2: in silico and molecular dynamics approach.
Chakraborty C; Sharma AR; Mallick B; Bhattacharya M; Sharma G; Lee SS
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1708-1723. PubMed ID: 33629340
[TBL] [Abstract][Full Text] [Related]
33. Molecular Dynamics Studies on the Structural Characteristics for the Stability Prediction of SARS-CoV-2.
Choi KE; Kim JM; Rhee J; Park AK; Kim EJ; Kang NS
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445414
[TBL] [Abstract][Full Text] [Related]
34. COVID-19: docking-based virtual screening and molecular dynamics study to identify potential SARS-CoV-2 spike protein inhibitors from plant-based phenolic compounds.
Moradkhani S; Farmani A; Saidijam M; Taherkhani A
Acta Virol; 2021; 65(3):288-302. PubMed ID: 34565157
[TBL] [Abstract][Full Text] [Related]
35. Biomechanical Characterization of SARS-CoV-2 Spike RBD and Human ACE2 Protein-Protein Interaction.
Cao W; Dong C; Kim S; Hou D; Tai W; Du L; Im W; Zhang XF
bioRxiv; 2020 Jul; ():. PubMed ID: 32766576
[TBL] [Abstract][Full Text] [Related]
36.
Rout J; Swain BC; Tripathy U
J Biomol Struct Dyn; 2022 Feb; 40(2):860-874. PubMed ID: 32938313
[TBL] [Abstract][Full Text] [Related]
37. The polybasic insert, the RBD of the SARS-CoV-2 spike protein, and the feline coronavirus - evolved or yet to evolve.
Budhraja A; Pandey S; Kannan S; Verma CS; Venkatraman P
Biochem Biophys Rep; 2021 Mar; 25():100907. PubMed ID: 33521335
[TBL] [Abstract][Full Text] [Related]
38. ADAM-15 disintegrin-like domain structure and function.
Lu D; Scully M; Kakkar V; Lu X
Toxins (Basel); 2010 Oct; 2(10):2411-27. PubMed ID: 22069559
[TBL] [Abstract][Full Text] [Related]
39. An Active Site Inhibitor Induces Conformational Penalties for ACE2 Recognition by the Spike Protein of SARS-CoV-2.
Williams-Noonan BJ; Todorova N; Kulkarni K; Aguilar MI; Yarovsky I
J Phys Chem B; 2021 Mar; 125(10):2533-2550. PubMed ID: 33657325
[TBL] [Abstract][Full Text] [Related]
40. Molecular dynamic simulation analysis of SARS-CoV-2 spike mutations and evaluation of ACE2 from pets and wild animals for infection risk.
Chen P; Wang J; Xu X; Li Y; Zhu Y; Li X; Li M; Hao P
Comput Biol Chem; 2022 Feb; 96():107613. PubMed ID: 34896769
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
